Sysmex
Sysmex Gets Approval in Japan for Retinal Dystrophy Gene Panel
The next-generation sequencing panel identifies genetic mutations that cause inherited retinal dystrophy, which results in vision problems, including blindness.
Juntendo University, Sysmex, and ThinkCyte Collaborating on Tests, Treatments for CML
The parties will use ThinkCyte's Ghost Cytometry technology to develop better diagnostics for early detection of blood cancers and advance treatment of CML.
Sysmex Inostics, Genomic Testing Cooperative Partner on Cancer Assay Services
Sysmex will add GTC's suite of liquid biopsy and tissue sequencing tests to the other genomic assays it offers to global biopharma customers.
Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area.
Qiagen, Sysmex Form Global Companion Diagnostic Development Pact
The companies will develop and commercialize liquid biopsy CDx assays using Sysmex's Plasma-Safe-SeqS next-generation sequencing technology.
Feb 11, 2020
Jul 27, 2017
BioMérieux, Sysmex Dissolve Japanese Joint Venture
May 31, 2017
Sysmex to Acquire Oxford Gene Technology
Apr 15, 2016
Feb 29, 2016